C2DX
Investing In and Evolving Products to their Fullest Potential BY SARAH HOLLINGSWORTH, DIRECTOR OF MARKETING, C2DX
C2Dx, Inc is a privately held medical device company based in Kalamazoo, Michigan with a unique business model. Founded in early 2019 by industry experts, C2Dx continues to build its business from the strong foundation of its initial acquisition of the STIC Intra-Compartmental Pressure Monitor from Stryker. Seeing success from giving this product dedicated attention has provided the opportunity to invest in additional acquisitions while continually evolving to ensure that healthcare providers have the devices, technology and service they need. The company is led by a team of medical device industry executives with over a century of experience managing growth-oriented teams across the globe. The company was founded on two principles: 1) continue the legacy of the STIC Pressure Monitor and 2) grow its offering by investing in other valuable products. “Since its introduction over 30 years ago, the product has been cited in numerous articles and papers due to its clinical effectiveness, accuracy, and reliability,” said Kevin McLeod, founder, president and CEO of C2Dx. “While at Stryker, I had the pleasure of being intricately involved with building the legacy and growth of this product and wanted to carry it on.” The STIC Pressure Monitor is a convenient, compact, reliable unit for both an immediate and/or continuous reading of compartment pressure. It was designed to aid in the diagnosis of compartment syndrome, which occurs when excessive pressure builds up within a muscle space in the body, often the lower leg or forearm. “There are very few emergencies in orthopedics- compartment syndrome
10
MICHBIO | michbio.org
is one of them,” said Dr. Christopher LeBrun (Orthopedic Trauma Surgery, Shock Trauma Center at University of Maryland Medical Center). One common diagnostic method is clinically assessing the patient using the 5 P’s (pain, pallor, pulselessness, paralysis, paresthesia). Statistically, this method performs poorly when used as a diagnostic tool. Studies have proven sensitivity rates as low as 13-54% using this method, while the STIC Pressure Monitor yields sensitivity rates of 94%. In addition to its clinical success, the STIC Pressure Monitor has become known for its rapid set-up, accuracy, convenience, and cost effectiveness. Through the success of the STIC Pressure Monitor, C2Dx has been able to make additional acquisitions while evolving its business practices to better support both its customers and community. The current C2Dx product portfolio highlights the company’s unique acquisition strategy of integrating industry-trusted products with untapped potential that could benefit from the team’s go-to market talents and innovative methods. The second product line, also from Stryker, was the T/ Pump Localized Temperature Therapy System. The T/Pump provides localized controlled warming and cooling temperature therapy with multiple treatment cycle
